BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu D, Wang C, Zhu X, Zhao W, Jiang B, Cui S, Sun Y, Cui Z. The antidepressant-like effects of fluvoxamine in mice involve the mTOR signaling in the hippocampus and prefrontal cortex. Psychiatry Res 2020;285:112708. [PMID: 31810748 DOI: 10.1016/j.psychres.2019.112708] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kato T. Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.109325] [Reference Citation Analysis]
2 Sokół A, Koroniak H, Hoffmann M, Siodła T. Naphthalene vs. Benzene as a Transmitting Moiety: Towards the More Sensitive Trifluoromethylated Molecular Probes for the Substituent Effects. Molecules 2022;27:4173. [DOI: 10.3390/molecules27134173] [Reference Citation Analysis]
3 Lewis V, Rodrigue B, Arsenault E, Zhang M, Taghavi-Abkuh FF, Silva WCC, Myers M, Matta-Camacho E, Aguilar-Valles A. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders. J Neurochem 2022. [PMID: 35680556 DOI: 10.1111/jnc.15652] [Reference Citation Analysis]
4 Sun Z, Jia L, Shi D, He Y, Ren Y, Yang J, Ma X. Deep brain stimulation improved depressive-like behaviors and hippocampal synapse deficits by activating the BDNF/mTOR signaling pathway. Behav Brain Res 2022;419:113709. [PMID: 34890598 DOI: 10.1016/j.bbr.2021.113709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Elias E, Zhang AY, Manners MT. Novel Pharmacological Approaches to the Treatment of Depression. Life 2022;12:196. [DOI: 10.3390/life12020196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Xiao H, Zhang Q, Zhong P, Tang G, Tao L, Huang Z, Guo D, Liao Y, Peng Y, Wu ZL, Wang Y, Ye WC, Shi L. Securinine Promotes Neuronal Development and Exhibits Antidepressant-like Effects via mTOR Activation. ACS Chem Neurosci 2021;12:3650-61. [PMID: 34541857 DOI: 10.1021/acschemneuro.1c00381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Duru CE, Umar HIU, Duru IA, Enenebeaku UE, Ngozi-Olehi LC, Enyoh CE. Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective. Environ Anal Health Toxicol 2021;36:e2021010-0. [PMID: 34130375 DOI: 10.5620/eaht.2021010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Irwin MN, VandenBerg A. Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action. Ment Health Clin 2021;11:200-10. [PMID: 34026396 DOI: 10.9740/mhc.2021.05.200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pałucha-Poniewiera A, Podkowa K, Rafało-Ulińska A. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice. Prog Neuropsychopharmacol Biol Psychiatry 2021;109:110239. [PMID: 33400944 DOI: 10.1016/j.pnpbp.2020.110239] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
10 Wang JL, Wang Y, Gao TT, Liu L, Wang YJ, Guan W, Chen TT, Zhao J, Zhang Y, Jiang B. Venlafaxine protects against chronic stress-related behaviors in mice by activating the mTORC1 signaling cascade. J Affect Disord 2020;276:525-36. [PMID: 32871684 DOI: 10.1016/j.jad.2020.07.096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]